This CME series takes an evidence-based and compassionate look at obesity as a chronic, multifactorial disease rather than a personal failing. It explores the shift from stigma to science in obesity management, highlighting the biological, behavioral, and societal factors that influence the condition. The sessions also delve into emerging therapies—particularly the expanding role of GLP-1 receptor agonists—to provide healthcare professionals with the latest insights on efficacy, safety, and holistic patient care.
With Admin
Published on 19th August 2025
With Admin
Published on 16th September 2025
Get notifications and offers as they happen.